Block listing Interim Review

RNS Number : 2536S
Dechra Pharmaceuticals PLC
15 March 2021
 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to a ris.

 

Date: 15 March 2021

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Approved Share Option Scheme

Period of return:

From:

15 September 2020

To:

14 March 2021

Balance of unallotted securities under scheme(s) from previous return:

3,844

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

1,844

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

2,000

 

 
         

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to a ris.

 

Date: 15 March 2021

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Unapproved Share Option Scheme

Period of return:

From:

15 September 2020

To:

14 March 2021

Balance of unallotted securities under scheme(s) from previous return:

66,320

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

14,352

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

51,968

 

 
         

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to a ris.

 

Date: 15 March 2021

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

SAYE Scheme

Period of return:

From:

15 September 2020

To:

14 March 2021

Balance of unallotted securities under scheme(s) from previous return:

45,617

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

50,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

60,542

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

35,075

 

 
         

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

 

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to a ris.

 

Date: 15 March 2021

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Global Save As You Earn Plan 2018

Period of return:

From:

15 September 2020

To:

14 March 2021

Balance of unallotted securities under scheme(s) from previous return:

70,000

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

136

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

69,864

 

 
         

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

 

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to a ris.

 

Date: 15 March 2021

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

2017 Long Term Incentive Plan

Period of return:

From:

15 September 2020

To:

14 March 2021

Balance of unallotted securities under scheme(s) from previous return:

175,000

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

195,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

68,402 

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

301,598

 

 
         

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRFIFSAVRIELIL

Companies

Dechra Pharmaceuticals (DPH)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today